Mitochondrial Fidelity and Homeostasis
线粒体保真度和稳态
基本信息
- 批准号:10597652
- 负责人:
- 金额:$ 8.2万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-06-01 至 2025-03-31
- 项目状态:未结题
- 来源:
- 关键词:AddressAgeAmyotrophic Lateral SclerosisBioenergeticsBiogenesisBiologicalCardiovascular DiseasesCell SurvivalCell physiologyCellsClinicalDedicationsDefectDegenerative DisorderDementiaDevelopmentDiseaseDissectionEtiologyEventFailureGlaucomaGoalsHealthHomeostasisHumanInner mitochondrial membraneInvestigationKnowledgeLife Cycle StagesMalignant NeoplasmsMediatingMitochondriaMitochondrial MatrixModelingMolecularNeuropathyOrganellesOrganismOutcomeParkinsonian DisordersPathologyPathway interactionsPhysiologicalProcessProphylactic treatmentProteinsProteomeQuality ControlRegulationResearchRoleSaccharomyces cerevisiaeSignal TransductionTherapeuticTimeVisionWorkYeastscost effective treatmenteffective therapyhearing impairmentinsightmitochondrial metabolismnovelpreservationprogramsprotein complexproteostasisrepairedspatiotemporal
项目摘要
PROJECT SUMMARY/ABSTRACT
The overall vision of the proposed research program is to determine how evolutionary conserved
mitochondrial quality control modules function to maintain cell survival, and how these functions can be
manipulated to achieve clinical benefits. Research in the Khalimonchuk lab is focused on providing a better
understanding of multilayered processes that mediate mitochondrial biogenesis, function and integrity. The
general goals include: 1) thorough molecular characterization of factors involved; 2) dissection of their roles
and concerted action in relevant biological mechanisms; and 3) investigation of associated regulatory and
signaling events and their potential therapeutic relevance. To that end, this MIRA proposal focuses on a group
of fundamental mechanisms that mediate mitochondrial fidelity and preserve normal mitochondrial functions
throughout a lifecycle of a cell/organism. The mitochondria and its complex protein homeostasis (proteostasis)
network involve multiple dynamic processes and pathways that adapt to homeostatic challenges and change
over time. The multifaceted biological roles of these mechanisms are highly relevant to both normal cellular
physiology and a wide range of human disorders for which no effective therapies presently exist. Progressive
mitochondrial failure has emerged as a central causative factor of prevalent degenerative diseases such as
glaucoma, hearing loss, Parkinsonism, amyotrophic lateral sclerosis, various neuropathies, dementia,
cardiovascular disorders, and certain cancers. In spite of much research, the molecular etiology of these
pathologies remains obscure. Thus, a greater understanding of the mechanisms that mediate mitochondrial
fidelity, function, and integrity, and how failure of these mechanisms drives the above clinical manifestations, is
of central importance. Unified by an overarching topic of mitochondrial fidelity and protein homeostasis, this
research program seeks to study: 1) the mechanisms that proteolytically control/regulate protein stability,
abundance, assembly, and repair within the inner mitochondrial membrane and 2) how a delicate protein
homeostasis in the mitochondrial matrix is established and maintained. In each case, the proposed work will
focus on a group of dedicated versatile factors that mediate mitochondrial self-preservation and are highly
relevant to human health. The goal is to address unresolved questions concerning the functional roles of key
molecular factors using two lauded complementary models, the yeast Saccharomyces cerevisiae and cultured
human cells. The research will uncover novel mechanisms of regulation, dynamic integration, and concerted
spatiotemporal action that are critical for mitochondrial sub-proteomes to adjust to homeostatic insults and
physiological demands and challenges. Successful outcomes from this project will provide unprecedented
insights into the coordination of mitochondrial metabolism, bioenergetics, and proteostasis and challenge
current views on mechanisms of age-associated maladies. They may also aid in the development of new
treatment/prophylaxis strategies against degenerative diseases and related pathologies that occur with age.
项目总结/摘要
拟议研究计划的总体愿景是确定进化如何保守
线粒体质量控制模块的功能,以维持细胞的生存,以及如何这些功能可以
以实现临床效益。Khalimonchuk实验室的研究重点是提供一个更好的
了解介导线粒体生物发生、功能和完整性的多层过程。的
总体目标包括:1)彻底的分子特征的因素参与; 2)解剖他们的作用
相关生物学机制中的协同作用; 3)相关调节和
信号事件及其潜在的治疗相关性。为此,这个MIRA提案的重点是一组
介导线粒体保真度和保持正常线粒体功能的基本机制
在细胞/有机体的整个生命周期中。线粒体及其复合蛋白质稳态(Proteostasis)
网络涉及多种动态过程和途径,以适应稳态挑战和变化
随着时间这些机制的多方面生物学作用与正常细胞和细胞外基质高度相关。
生理学和广泛的人类疾病,目前还没有有效的治疗方法。进步
线粒体衰竭已经成为流行的退行性疾病的主要致病因素,
青光眼、听力损失、帕金森综合征、肌萎缩侧索硬化、各种神经病、痴呆,
心血管疾病和某些癌症。尽管有很多研究,但这些疾病的分子病因学
病理学仍不清楚。因此,更好地了解介导线粒体
保真度,功能和完整性,以及这些机制的失败如何驱动上述临床表现,
至关重要。由线粒体保真度和蛋白质稳态的总体主题统一,
研究计划旨在研究:1)蛋白水解控制/调节蛋白质稳定性的机制,
丰富,组装和修复内线粒体膜和2)如何微妙的蛋白质
线粒体基质中的稳态得以建立和维持。在每一种情况下,拟议的工作将
专注于一组专用的多功能因子,介导线粒体自我保护,
与人类健康有关。目标是解决有关关键职能作用的未解决问题,
分子因素使用两个称赞互补模型,酵母酿酒酵母和培养
人类细胞。这项研究将揭示新的监管机制,动态整合,协调一致,
时空作用对于线粒体亚蛋白质组调节稳态损伤至关重要,
生理需求和挑战。该项目的成功成果将提供前所未有的
深入了解线粒体代谢,生物能量学和蛋白质稳态的协调和挑战
目前对年龄相关疾病机制的看法。它们还可以帮助开发新的
针对随年龄发生的退行性疾病和相关病理的治疗/预防策略。
项目成果
期刊论文数量(12)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
The mitochondrial carrier SFXN1 is critical for complex III integrity and cellular metabolism.
- DOI:10.1016/j.celrep.2021.108869
- 发表时间:2021-03-16
- 期刊:
- 影响因子:8.8
- 作者:Acoba MG;Alpergin ESS;Renuse S;Fernández-Del-Río L;Lu YW;Khalimonchuk O;Clarke CF;Pandey A;Wolfgang MJ;Claypool SM
- 通讯作者:Claypool SM
Editorial: Special Issue on mitochondrial fidelity.
社论:线粒体保真度特刊。
- DOI:10.1016/j.mito.2019.12.007
- 发表时间:2020
- 期刊:
- 影响因子:4.4
- 作者:Khalimonchuk,Oleh
- 通讯作者:Khalimonchuk,Oleh
Short Communication: Beta-adrenergic agonists alter oxidative phosphorylation in primary myoblasts.
简短的交流:β-肾上腺素能激动剂改变原代成肌细胞的氧化磷酸化。
- DOI:10.1093/jas/skac208
- 发表时间:2022
- 期刊:
- 影响因子:3.3
- 作者:Sieck,RenaeL;Treffer,LeahK;Fuller,AnnaM;PonteViana,Martonio;Khalimonchuk,Oleh;Schmidt,TyB;Yates,DustinT;Petersen,JessicaL
- 通讯作者:Petersen,JessicaL
Coordination of metal center biogenesis in human cytochrome c oxidase.
- DOI:10.1038/s41467-022-31413-1
- 发表时间:2022-06-24
- 期刊:
- 影响因子:16.6
- 作者:Nyvltova, Eva;Dietz, Jonathan V.;Seravalli, Javier;Khalimonchuk, Oleh;Barrientos, Antoni
- 通讯作者:Barrientos, Antoni
Protease OMA1 modulates mitochondrial bioenergetics and ultrastructure through dynamic association with MICOS complex.
- DOI:10.1016/j.isci.2021.102119
- 发表时间:2021-02-19
- 期刊:
- 影响因子:5.8
- 作者:Viana MP;Levytskyy RM;Anand R;Reichert AS;Khalimonchuk O
- 通讯作者:Khalimonchuk O
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Oleh Khalimonchuk其他文献
Oleh Khalimonchuk的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Oleh Khalimonchuk', 18)}}的其他基金
A Conserved Metalloprotease Required for Mitochondrial Maintenance and Protection
线粒体维护和保护所需的保守金属蛋白酶
- 批准号:
8818735 - 财政年份:2014
- 资助金额:
$ 8.2万 - 项目类别:
A Conserved Metalloprotease Required for Mitochondrial Maintenance and Protection
线粒体维护和保护所需的保守金属蛋白酶
- 批准号:
8920657 - 财政年份:2014
- 资助金额:
$ 8.2万 - 项目类别:
A Conserved Metalloprotease Required for Mitochondrial Maintenance and Protection
线粒体维护和保护所需的保守金属蛋白酶
- 批准号:
9277480 - 财政年份:2014
- 资助金额:
$ 8.2万 - 项目类别:
相似国自然基金
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
- 批准号:JCZRQN202500010
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
- 批准号:2025JJ70209
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
- 批准号:
- 批准年份:2024
- 资助金额:0 万元
- 项目类别:面上项目
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
- 批准号:2023JJ50274
- 批准年份:2023
- 资助金额:0.0 万元
- 项目类别:省市级项目
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
- 批准号:
- 批准年份:2022
- 资助金额:33 万元
- 项目类别:地区科学基金项目
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
- 批准号:n/a
- 批准年份:2022
- 资助金额:10.0 万元
- 项目类别:省市级项目
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
- 批准号:81973577
- 批准年份:2019
- 资助金额:55.0 万元
- 项目类别:面上项目
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
- 批准号:81602908
- 批准年份:2016
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
高血糖激活滑膜AGE-RAGE-PKC轴致骨关节炎易感的机制研究
- 批准号:81501928
- 批准年份:2015
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
相似海外基金
PROTEMO: Emotional Dynamics Of Protective Policies In An Age Of Insecurity
PROTEMO:不安全时代保护政策的情绪动态
- 批准号:
10108433 - 财政年份:2024
- 资助金额:
$ 8.2万 - 项目类别:
EU-Funded
The role of dietary and blood proteins in the prevention and development of major age-related diseases
膳食和血液蛋白在预防和发展主要与年龄相关的疾病中的作用
- 批准号:
MR/X032809/1 - 财政年份:2024
- 资助金额:
$ 8.2万 - 项目类别:
Fellowship
Atomic Anxiety in the New Nuclear Age: How Can Arms Control and Disarmament Reduce the Risk of Nuclear War?
新核时代的原子焦虑:军控与裁军如何降低核战争风险?
- 批准号:
MR/X034690/1 - 财政年份:2024
- 资助金额:
$ 8.2万 - 项目类别:
Fellowship
Collaborative Research: Resolving the LGM ventilation age conundrum: New radiocarbon records from high sedimentation rate sites in the deep western Pacific
合作研究:解决LGM通风年龄难题:西太平洋深部高沉降率地点的新放射性碳记录
- 批准号:
2341426 - 财政年份:2024
- 资助金额:
$ 8.2万 - 项目类别:
Continuing Grant
Collaborative Research: Resolving the LGM ventilation age conundrum: New radiocarbon records from high sedimentation rate sites in the deep western Pacific
合作研究:解决LGM通风年龄难题:西太平洋深部高沉降率地点的新放射性碳记录
- 批准号:
2341424 - 财政年份:2024
- 资助金额:
$ 8.2万 - 项目类别:
Continuing Grant
Walkability and health-related quality of life in Age-Friendly Cities (AFCs) across Japan and the Asia-Pacific
日本和亚太地区老年友好城市 (AFC) 的步行适宜性和与健康相关的生活质量
- 批准号:
24K13490 - 财政年份:2024
- 资助金额:
$ 8.2万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Discovering the (R)Evolution of EurAsian Steppe Metallurgy: Social and environmental impact of the Bronze Age steppes metal-driven economy
发现欧亚草原冶金的(R)演变:青铜时代草原金属驱动型经济的社会和环境影响
- 批准号:
EP/Z00022X/1 - 财政年份:2024
- 资助金额:
$ 8.2万 - 项目类别:
Research Grant
ICF: Neutrophils and cellular senescence: A vicious circle promoting age-related disease.
ICF:中性粒细胞和细胞衰老:促进与年龄相关疾病的恶性循环。
- 批准号:
MR/Y003365/1 - 财政年份:2024
- 资助金额:
$ 8.2万 - 项目类别:
Research Grant
Doctoral Dissertation Research: Effects of age of acquisition in emerging sign languages
博士论文研究:新兴手语习得年龄的影响
- 批准号:
2335955 - 财政年份:2024
- 资助金额:
$ 8.2万 - 项目类别:
Standard Grant
Shaping Competition in the Digital Age (SCiDA) - Principles, tools and institutions of digital regulation in the UK, Germany and the EU
塑造数字时代的竞争 (SCiDA) - 英国、德国和欧盟的数字监管原则、工具和机构
- 批准号:
AH/Y007549/1 - 财政年份:2024
- 资助金额:
$ 8.2万 - 项目类别:
Research Grant